Oxygen Biotherapeutics to present at BIO CEO and Investor Conference

The BIO CEO and Investor Conference takes place in New York next month.

Oxygen Biotherapeutics has announced that the company will present a corporate overview and update at the 15th annual BIO CEO and Investor Conference, due to be held at the Waldorf Astoria Hotel in New York next month.

Company president and chief financial officer Michael Jebson will deliver the presentation at the event, which takes place over February 11th and 12th.

The conference is organised by the Biotechnology Industry Organization and is designed to offer companies in the sector new opportunities for networking, establishing partnerships and attracting investors. It is the largest event of its kind for investors focused on established an emerging public biotech companies and it will provide a forum for meetings of investors, industry business directors and licencing heads.

There will also be special industry spotlights on how biotechnology is already being used in the everyday world and the use of agricultural biotechnology, as well as how it can help boost food production around the world.
Visitors will be able to discus industry best practices including support of bioscience initiatives; and growing jobs through biotechnology industry development.